Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea

Author： Jang Geundoo   Lee Sung   Ahn Jin-Hee   Jung Kyung   Lee Hyunjoo   Gong Gyungyub   Kim Hak-Hee   Ahn Seung   Son Byung   Ahn Sei-Hyun   Kim Sung-Bae  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.1, 2011-07, pp. : 171-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

By Lin Nancy   Freedman Rachel   Ramakrishna Naren   Younger Jerry   Storniolo Anna   Bellon Jennifer   Come Steven   Gelman Rebecca   Harris Gordon   Henderson Mark   MacDonald Shannon   Mahadevan Anand   Eisenberg Emily   Ligibel Jennifer   Mayer Erica   Moy Beverly   Eichler April   Winer Eric  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 405-414

Springer Publishing Company

Access to resources Recommend Favorite

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

By Aurilio Gaetano   Monfardini Lorenzo   Rizzo Stefania   Sciandivasci Angela   Preda Lorenzo   Bagnardi Vincenzo   Disalvatore Davide   Pruneri Giancarlo   Munzone Elisabetta   Della Vigna Paolo   Renne Giuseppe   Bellomi Massimo   Curigliano Giuseppe   Goldhirsch Aron   Nolè Franco  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1649-1656

Informa Healthcare

Access to resources Recommend Favorite

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

By Alvarez Ricardo  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2positive breast cancer in Japan

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1268-1274

Science Publishers

Access to resources Recommend Favorite